A Prospective Randomised Controlled Trial of Management of Recurrent Nosebleeds in Children
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00390663
Verified October 2006 by NHS Greater Glasgow Yorkhill Division. Recruitment status was: Recruiting
To determine whether the selective application of a combined treatment regimen of silver nitrate cautery and 4 weeks of Naseptin cream is superior to naseptin treatment alone in the management of recurrent paediatric epistaxis.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
1 Year to 14 Years (Child)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Children aged 1 - 14
History of repeated epistaxis with at least 1 episode in the previous 4 weeks prior to attending the ENT clinic.
Presence of prominent vessels on the anterior nasal septum on the side that reportedly bleeds (or on at least one side if bleeding is reported to be bilateral)
No prominent vessels on examination (these children will be randomised but will be prescribed Naseptin alone and followed up in the same way as the children in the trial, for completeness of data)